Tag Archives: fda

FDA warns of HORV risk with compounded vancomycin

The FDA is recommending against the use of prophylactic intraocular vancomycin, alone or in a compounded drug combining multiple agents, during cataract surgery due to the risk of hemorrhagic occlusive retinal vasculitis (HORV).[Read More ] Source: Daily Dose of Eye Care